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Cigarette smoke is associated to pathological weakening of bone tissue, being considered an
important playmaker in conditions such as osteoporosis and periodontal bone loss. In addition, it
is also associated with an increased risk of failure in bone regeneration strategies. The present
work aimed to characterize the effects of nicotine on human osteoclastogenesis over a
hydroxyapatite substrate.Osteoclast precursorsweremaintained in the absence or presence of
the osteoclastogenesis enhancers M-CSF and RANKL, and were further treated with nicotine
levels representative of the concentrations observed in the plasma and saliva of smokers. It was
observed that nicotine at low concentrations elicit an increase in osteoclast differentiation, but
only in the presence ofM-CSF andRANKL itwas also able to significantly increase the resorbing
ability of osteoclasts. A slight downregulation of NFkB pathway and an increase in the
production of TNF-α and, particularly PGE2, were involved in the observed effects of nicotine.
At high concentrations, nicotine revealed cytotoxic effects, causing a decrease in cell density. In
conclusion, nicotine at levels found in the plasmaof the smokers, has the ability to act directly on
osteoclast precursors, inducing its osteoclastogenic differentiation. The stimulatory behavior
appears to be dependent on the stage of osteoclastic differentiation of the precursor cells,
whichmeans, in the absence ofM-CSF and RANKL, it only favors the initial stages of osteoclast
differentiation, while in the presence of the growth factors, a significant increase in their
resorbing ability is also achieved.
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1 | INTRODUCTION
Osteoclasts are multinucleated cells specialized in bone resorption.
They are originated from the fusion and further differentiation of
mononuclear precursors that belong to the CD14+ monocyte/
macrophage lineage (Datta, Ng, Walker, Tuck, & Varanasi, 2008;
Vaananen & Laitala-Leinonen, 2008). Osteoclastogenesis is a complex
process that requires an intricate network of cellular crosstalks
involving many signaling molecules, including the main activators
M-CSF and RANKL (Boyle, Simonet, & Lacey, 2003; Datta et al., 2008;
Zhao, Shao, Chen, & Li, 2007). Once committed to osteoclast
development, precursor cells pass through multiple steps of intracel-
lular rearrangements that ultimately lead to the generation of mature,
bone-resorbing osteoclasts. One important mediator of the final
events of osteoclast activation is the tyrosine-kinase c-src (Boyle et al.,
2003; Zhao et al., 2007). Once activated, they start to transport H+ to
the extracellular bone surface, eroding the bone hydroxyapatite
crystals and, at the same time, they secrete lytic enzymes, especially
cathepsin K, that degrade the organic components of bone matrix
(Boyle et al., 2003; Vaananen & Laitala-Leinonen, 2008).
Cigarette smoke has been associated with several bone dis-
turbances like osteoporosis and periodontal bone loss (Ahmed &
Mohammed, 2002; Baheiraei, Pocock, Eisman, Nguyen, & Nguyen,
2005; Balatsouka, Gotfredsen, Lindh, & Berglundh, 2005; Law &
Hackshaw, 1997). These conditions may be attributed partly to the
known inflammatory effects of tobacco smoke, although a direct
effect on bone cells may also occur. Tobacco smoke contains more
than a thousand of potentially toxic substances, but nicotine has been
suggested as a keymolecule toward the understanding of the negative
effects of smoking on bone tissue (Pereira, Carvalho, Peres, &
Fernandes, 2009; Seiichi et al., 2010). It is known that nicotine
negatively affects blood flow to the bone and surrounding tissues,
which difficult the healing processes and can also lead to problems
related with the delivery of nutrients to bone cells (Jeffrey, John, Kun,
Peiman, & Dave, 1999). As a consequence, nicotine can cause bone
graft morbidity and impaired bone healing, and also compromise the
success of bone regeneration strategies (Law & Hackshaw, 1997). In
addition, a direct effect of nicotine on bone cells may also contribute to
the observed deleterious effects of smoking in bone tissue (Balatsouka
et al., 2005).
Several studies have shown that nicotine modulates osteoblast
activity in a dose-dependent way (Pereira, Carvalho, Peres, Gutierres,
& Fernandes, 2008; Pereira et al., 2009). Overall, and despite
the variability of the available information, due to the different
experimental protocols regarding nicotine levels, exposure conditions
and cell culture models, results about the effect of nicotine on
osteoblastic cells show that this molecule may play a significant role in
the modulation of bone metabolic activities, suggesting a potential
impact in the overall bone health (Pereira et al., 2008, 2009; Seiichi
et al., 2010; Yuhara et al., 1999). By contrast, the effects of nicotine on
osteoclastic cells, the other key player in bone remodeling and
regeneration, are scarcely documented. The few published studies
were not conducted with human cells, instead it was used mouse and
porcine cells (Henemyre et al., 2003; Tanaka et al., 2013; Yuhara et al.,
1999). It was reported that co-cultures of mouse bone marrow and
ST2 cells displayed an inhibition of osteoclastogenesis caused by
nicotine (Yuhara et al., 1999). In another study, nicotine stimulated the
resorbing activity of porcine osteoclastic cells (Henemyre et al., 2003),
whereas, in a more recent work, nicotine reduced the resorbing ability
of RAW264.7 murine cells (Tanaka et al., 2013). The different
protocols and the origin of the analyzed cells might explain the
apparent observed contradictions, and reinforces the need to address
this issue in more detail and in a more representative model, as in
human primary osteoclastic cells.
Since the inorganic matrix of bone tissue is mainly comprised by
combined calcium and phosphate ions, calcium phosphate bioma-
terials display good biocompatibility and osteoconductivity, having
an established clinical relevance in bone related applications
(Dimitriou, Jones, McGonagle, & Giannoudis, 2011). As such,
synthetic hydroxyapatite (HA), has been successfully used for
bone replacement/regeneration over the years (Rumpel et al.,
2006). Upon material implantation, osteoclastic cells are key
players in the cellular events occurring at the bone/HA interface.
Together with the osteoblastic cells, they are involved in the bone
regeneration process occurring at early implantation stages, due to
their high affinity for calcium phosphates surfaces, but also during
the subsequent local bone remodeling responsible for the mainte-
nance of the life-long mechanical and biological properties of
the regenerated bone (Datta et al., 2008). Thus, understanding
the effects of exogenous molecules, such as nicotine, in the bone
cells/HA interface is a critical issue for a long-term successful
implantation. However, this has not yet been documented regarding
the osteoclastic behavior.
In this context, the aim of this work is to provide a detailed
information on the dose- and time-dependent effects of nicotine in the
differentiation and functional activity of human osteoclastic cells
occurring over an HA substrate. For that, human osteoclastic
precursors were cultured over HA in the absence or the presence
of osteoclastogenic promoters (M-MSF and RANKL), for the evalua-
tion of the nicotine effects in unstimulated precursors and precursor
cells actively engaged in a differentiation process. Cell cultures were
exposed to a range of plasmatic and salivary nicotine concentrations
and were assessed for several osteoclast-related parameters. The
involvement of some signaling pathways on the cellular response was
also addressed.
2 | MATERIALS AND METHODS
2.1 | Preparation and characterization of
hydroxyapatite disks
Commercial Hydroxyapatite (HA) (Plasma Biotal Limited, Buxton,
UnitedKingdom)was used to prepare diskswith 16mmof diameter, as
described before (Costa-Rodrigues, Fernandes, Lopes, & Fernandes,
2012). The discs were obtained using 1 g of dry powder under uniaxial
compression stress of 140 kg/cm2 (Mestra snow P3). The sintering
temperature used was of 1,300°C, with a 15min plateau and applying
a heating rate of 20°C/min. The sintering cycle was completed with a
cooling process inside the furnace (Termolab/Eurotherm 2408). The
mass of the HA discs was assessed by using an analytical balance
(Metler AG285). After the sintering process, the disks were polished
with a Dual Disc Polishing Machine (Stuers Rotopol-1), with
waterproof sandpaper (# 320, # 500, and # 1000).
2.1.1 | X-ray diffraction (XRD) analysis
HAdiskswere ground and the resulting fine powderswere analyzed by
an X-ray diffraction Rigaku Dmax-III-VC, using a CU-Kα radiation
(Kα = 1.54056 Å). Datawere acquired for 2θ values between 4 and 80°
at intervals of 0.02°/s.
2.1.2 | Scanning electron microscopy (SEM)
Analyses were performed using a SEM microscope FEI Quanta
400FEG/EDAX Genesis X4M under vacuum conditions. HA disks
were coated with a thin film of gold using a sputter coater (SPI-Module)
in an atmosphere of argon before analysis.
2.2 | Osteoclastic cell cultures
Human peripheral blood mononuclear cells (PBMC) were used to
establish the osteoclastic cell cultures. PBMC were isolated from the
blood of healthy donors with 25–35 years old, after informed consent,
as described previously (Costa-Rodrigues et al., 2012). Briefly, blood
was diluted with PBS (1:1), supplemented with 2mM EDTA and
applied on top of Ficoll-Paque™ PREMIUM (GE Healthcare
Bio-Sciences). After centrifugation at 400g for 30min, PBMC were
recovered andwashed twicewith PBS+ 2mMEDTA. Typically, around
70 × 106 PBMC were obtained for each 100ml of processed blood.
PBMC cells were counted with a cytometer (Celltac MEK-5103).
PBMC (1.5 × 106 cells/cm2) were cultured in α-MEM supple-
mented with 30% human serum (from the same donor from which
PBMC were collected), 100 IU/ml penicillin, 2.5 μg/ml streptomycin,
2.5 μg/ml amphotericin B, and 2mM L-glutamine. PBMC were
cultured for 21 days in the absence (base medium, BM) or presence
(M+R) of the osteoclastogenic inducers M-CSF (25 ng/ml) and RANKL
(40 ng/ml) (Costa-Rodrigues et al., 2012). When indicated, 0.5 μg/ml
of isotype control or anti-RANKL antibodies (Abcam, Cambridge,
United Kingdom) were included in the culture media. Cell cultures
were incubated in a 5% CO2 humidified atmosphere at 37°C, and
culture medium was replaced once a week.
2.2.1 | Exposure to nicotine
As a preliminary experiment, unstimulated and stimulated PBMCwere
exposed to a wide concentration range of nicotine, that is, 1.28 ng/ml
to 500 μg/ml. Nicotine was added 24 hr after cell plating, and it was
present during the 21-day culture time, being renewed at each
medium change. Cultures were assessed for total protein content and
TRAP activity.
Based on this experiment, PBMC cultured over HA surface were
exposed to 1.28 ng/ml to 100 μg/ml nicotine, in conditions similar to
those described above, andwere characterized for total protein content
and TRAP activity; they were also observed by confocal laser scanning
microscopy (for the presence of actin rings and vitronectin and
calcitonin receptors) and by scanning electron microscopy. Cultures
treated with 1.28 and 32 ng/ml nicotine and 4 μg/ml, representative
concentrations of statistically significant effects on TRAP activity, were
characterized for the expression of several osteoclastic genes. Also,
PBMC cultures exposed to 32 ng/ml nicotine, which it was the
lowest tested concentration that elicited a significant effect on
osteoclastogenesis, both in BM and M+R conditions, were also
characterized for HA resorbing ability and for the involvement of
several intracellular pathways and RANKL signaling. The culture
medium was also analyzed for the levels of TNF-α and PGE2. Cultures
were assessed at days 14 and 21 as described below.
2.3 | Osteoclastogenic cell response
2.3.1 | Protein quantification
Quantification of total protein content was performed by Bradford’s
method (Bradford, 1976), using bovine serum albumin as a standard.
Shortly, cell cultureswerewashedwithPBS,solubilizedwith0.1MNaOH
and treated with Coomassie® Protein Assay Reagent (Fluka). After
incubation for 2min at room temperature, the 595 nm absorbance was
determined in an ELISA plate reader (Synergy HT, Biotek,Winooski, VT).
2.3.2 | TRAP activity
TRAP activity was assayed by para-nitrophenilphosphate (pNPP)
hydrolysis method. Cell cultures were washed twice with PBS and
solubilized with 0.1% (V/V) Triton X-100. Cellular extracts were
incubated with 12.5 mM pNPP in 0.04M tartaric acid and 0.09M
citrate (pH 4.8) for 1 hr at 37°C. After addition of 5M NaOH, the
absorbance of the samples was measured at 400 nm in an ELISA plate
reader (Synergy HT, Biotek). TRAP activity was normalized with total
protein content, quantified by Bradford’s method, and results were
expressed as nmol/min.µgprotein
−1.
2.3.3 | Apoptosis quantification
Apoptosis was evaluated by means of caspase-3 activity quantifica-
tion. PBMC cultures, at days 14 and 21, were washed twice in PBS and
assessed for caspase 3 activity with EnzCheck® Caspase-3 Assay Kit
#2 (Molecular Probes, Eugene), according to manufacturer’s instruc-
tions. Fluorescence was measured at 496/520 nm (excitation/
emission) in an ELISA plate reader (Synergy HT, Biotek). Results
obtained in each experimental condition were normalized by the value
obtained in the corresponding control (absence of nicotine) and
presented as a percentage.
2.3.4 | Cells with actin rings and expressing vitronectin and
calcitonin receptors
Cell cultures were fixed (3.7% (v/v) para-formaldehyde, 15min)
permeabilized (0.1% (v/v) Triton X-100, 5min) and stained for actin
with 5 U/ml Alexa Fluor1 647-Phalloidin (Invitrogen, Carlsbad, CA), and
for vitronectin and calcitonin receptors (VNR and CTR) with 50mg/ml
mouse IgGs anti-VNR and IgGs anti-CTR (R&D Systems), respectively.
Detection of IgGs anti-VNR and IgGs anti-CTR was performed with
2mg/ml Alexa Fluor1 488-Goat anti-mouse IgGs. Cells were observed
under confocal laser scanning microscopy (CLSM).
2.3.5 | Quantitative real-time PCR analysis
PBMC cultures were analyzed by quantitative real-time PCR
(qPCR) for the expression of the housekeeping genes beta-
glucuronidase (GUSB) and proteasome subunit beta type-6
(PSMB6), and the osteoclast-related genes c-myc, c-src, TRAP,
CATK, and CA2 (Zhao et al., 2007). For that, RNA was isolated with
RNeasy® Mini Kit (Qiagen, Hilden, Germany) according to
manufacturer’s instructions. Reverse transcription cDNA synthesis
was performed with DyNAmo cDNA synthesis kit (Finnzymes,
Espoo, Finland) and random hexamers according to the manufac-
turer’s instructions. Then, cDNA samples (2 ng) were amplified in
with a DyNAmo Flash SYBR green qPCR kit (Finnzymes) on a
Rotor-Gene thermocycler (Qiagen). The annealing temperature
used was 55°C and the extension time was 15 s. The primers used
are listed in Table 1. The values obtained were normalized with the
results obtained for the two tested housekeeping genes.
2.3.6 | Quantification of Ca2+ levels in the culture medium
Ca2+ levels in the medium, collected at days 14 and 21, were analyzed
by using the the CalciFluor™ Assay, according to manufacturer’s
instructions. The fluorescence of the samples was measured in a
fluoremeter with plate reader (Synergy HT, Biotek) at 530/590 nm
(excitation/emission). The concentration of Ca2+ in the culture
medium was corrected taking into account the corresponding values
observed in the culture medium fromHA disks incubated without cells
and in the culture medium from PBMC cultures performed in standard
tissue culture plates.
2.3.7 | Scanning electron microscopy (SEM)
Cells were fixed (1.5% glutaraldehyde in 0.14M sodium cacodylate,
10 min), dehydrated in graded series of ethanol solutions and
critical-point dried. Specimens were mounted onto aluminium
supports using Araldite™ and then sputter-coated with palladium–
gold and observed in a Joel JSM 35C scanning electron microscope
equipped with an X-ray energy dispersive spectroscopy voyager
XRMA System (Noran Instruments, Pacifica, CA). Total resorbed area
was quantified. For that, cell layers were bleached, 10 micrographs
were randomly chosen for each experimental condition and the
resorption lacunae were identified. The corresponding areas were
calculated with ImageJ 1.41 software. Results were expressed as
the percentage of the total area of the micrographs that were
identified as resorption lacunae.
2.3.8 | Intracellular signaling mechanisms
PBMC cultures were treated with specific inhibitors of some
osteoclastogenic-related signaling pathways, namely: U0126, a MEK
signaling pathway inhibitor, thatwas tested at 1 and 10 μM,because of
the differing osteoclastogenic effects observed with low concen-
trations of this molecule (Costa-Rodrigues, Teixeira, & Fernandes,
2011; Hotokezaka et al., 2002; Kim et al., 2007; Yang et al., 2008);
PDTC, a NFkB signaling pathway inhibitor, was used at 10 and
100 μM, because the lower concentration has been previously
described as the IC50 on rat osteoclastic differentiation (Hall,
Schaeublin, Jeker, Fuller, & Chambers, 1995); indomethacin (1 μM) a
PGE2 synthesis blocker, was also included in the study, as PGE2 is
reported to be associated with an increase on osteoclastic develop-
ment (Kawashima, Fujikawa, Itonaga, Takita, & Tsumura, 2009;
Kellinsalmi et al., 2007). PBMC cultures were analyzed for TRAP
activity.
2.3.9 | TNF-α and PGE2 quantification on culture media
Culture medium from PBMC cultures was analyzed for TNF-α and
PGE2 levels, using the TNF alpha Human ELISA Kit (Abcam) and
Prostaglandin E2 ELISA Kit (Abcam), respectively, following manu-
facturer’s instructions. Absorbance of the samples was measured at
450 nm (TNF-α) and 405 nm (PGE2) in an ELISA plate reader (Synergy
HT, Biotek). Results were expressed as pg/ml.
2.4 | Statistical analysis
Data presented in this work are the means of three separate
experiments performed with cells from four different blood donors.
Statistical differences were assessed using an unpaired Student’s
t-test with Bonferroni correction formultiple comparisons. All data are
expressed as the mean ± standard. For values of p ≤ 0.05, differences
were considered statistically significant.
3 | RESULTS
3.1 | HA disks
HA disks were analyzed by SEM and XRD techniques (Figure 1). HA
displayed a regular surface with widespread small cavities (<10 μm)
(Figure 1a). XRD spectrum (Figure 1b), showed that the disks were
composed exclusively by HA, with a greater crystallinity between 30°
and 35° 2θ.
TABLE 1 Primers used on qPCR analysis of PBMC cultures
Gene 5′ Primer 3′ Primer
GUSB 5′-TGCAGCGGTCTGTACTTCTG-3′ 5′-CCTTGACAGAGATCTGGTAATTCA-3′
PSMB6 5′-GCCGGCTACCTTACTACCTG-3′ 5′-AAACTGCACGGCCATGATA-3′
TRAP 5′-ACCATGACCACCTTGGCAATGTCTC-3′ 5′-ATAGTGGAAGCGCAGATAGCCGTT-3′
CATK 5′-AGGTTCTGCTGCTACCTGTGGTGAG-3′ 5′-CTTGCATCAATGGCCACAGAGACAG-3′
CA2 5′-GGACCTGAGCACTGGCATAAGGACT-3′ 5′-AAGGAGGCCACGAGGATCGAAGTT-3′
c-myc 5′-TACCCTCTCAACGACAGCAG-3′ 5′-TCTTGACATTCTCCTCGGTG-3′
c-src 5′-AAGCTGTTCGGAGGCTTCAA-3′ 5′-TTGGAGTAGTAGGCCACCAG-3′
FIGURE 1 HA disks characterization by SEM (a) and XRD (b)
3.2 | Dose-response effect of nicotine on TRAP
activity by PBMC cultures
Control PBMC cultures performed in base medium (BM) presented low
protein content, and nicotine at concentrations higher than 20 μg/ml
elicited a dose-dependent decrease. Regarding TRAP activity, PBMC
cultures maintained in BM revealed low enzyme activity, and exposure
to nicotine caused an inductive effect at concentrations of 32 to
800 ng/ml (39–97% at day 21), and a dose-dependent decrease at
higher levels. Caspase-3 activity was significantly increased, either at
day 14 or 21, in the presence of nicotine concentrations ≥20μg/ml
(18–51% or 20–62%, respectively). PBMC cultures supplemented with
M-CSF and RANKL (M+R) presented a significantly higher protein
content andTRAPactivity. Nicotine, at concentrations >4 μg/ml caused
a dose-dependent decrease in total protein content.Moreover, nicotine
at 6.4 and32 ng/ml increased TRAPactivity at day 21 (∼30%); exposure
to levels ≥0.8 μg/ml resulted in dose-dependent negative effects.
Apoptosiswas stimulated by nicotine at concentrations≥4 μg/ml, being
26–66% higher than the control at day 14, and 31–70% at day 21.
Results are summarized in Figure 2.
3.3 | Effect of nicotine on osteoclastogenesis over a
HA substrate
3.3.1 | TRAP activity
The effect of nicotine on PBMC cultured over the HA surface was
similar to that observed in standard tissue culture plates (Figure 3a),
that is, total protein content was only affected (negatively) by high
nicotine concentrations (Figure 3a), and there was an inductive effect
on TRAP activity at ∼32 ng/ml nicotine, and an inhibitory effect at
higher levels (Figure 3b).
3.3.2 | Presence of cells with actin rings and expressing
VNR and CTR
PBMC displayed well-defined actin rings and VNR and CTR, as
observed by CLSM. Overall, both in control conditions and in the
presence of nicotine, the amount of osteoclastic cells was in line
with the results obtained for TRAPactivity. Representativemicrographs
of PBMC cultures, exposed to 32 ng/ml nicotine, are depicted in
Figure 3c.
FIGURE 2 Dose-response effects of nicotine on human osteoclastic cells. Total protein content, TRAP activity and apoptosis were measured
in unstimulated (base medium, BM) and stimulated (M-CSF and RANKL, M+R) PBMC cultures. *Significantly different from the control
3.3.3 | Expression of osteoclast-related genes
PBMC cultures were assessed by qPCR for the expression of c-myc,
c-src, TRAP, CATK, and CA2 (Figure 3d). In BM, nicotine at 1.28 ng/ml
did not significantly affect gene expression; at 32 ng/ml it only
stimulated the expression of the gene coding for TRAP, while the
expression of the remaining genes was not affected (∼23%); finally, at
4 μg/ml it elicited a decrease in TRAP and CA2 gene expression (∼13%
and ∼29%, respectively). Compared to the control, cell cultures
performed in M+R and treated with 32 ng/ml nicotine, revealed a
higher gene expression of all tested genes, except CA2; the maximum
increase was observed for c-src and CATK (∼57 and 64%,
FIGURE 3 Osteoclastic cell behavior over HA disks. Unstimulated (base medium, BM) and stimulated (M-CSF and RANKL, M+R) PBMC
cultures were exposed to nicotine and analyzed for total protein content (a), TRAP activity (b), presence of cells with actin rings (blue) and
expressing VNR and CTR (green) observed by CLSM (c), and expression of osteoclast-related genes by qPCR (d). *Significantly different from
the control
respectively). On the other hand, supplementation with 4 μg/ml
nicotine elicited a significant decrease (∼13–22%) in the expression of
all the tested genes.
3.3.4 | Levels of Ca2+ released into culture media and total
resorbed area
In control PBMC cultures performed in base medium, the amount of
Ca2+ present in culturemediumwas low, but it increased significantly in
the cultures supplemented with M-CSF and RANKL. Nicotine, at
32 ng/ml, did not significantly affect the concentration of Ca2+ in the
culturemedium collected from the cultures performed in basemedium.
However, in stimulated PBMC cultures, the presence of 32 ng/ml
nicotine greatly increased Ca2+ levels in the medium (∼60% at day 21).
Results are presented in Figure 4a. Regarding total resorbed area, in BM
conditions it was not observed the formation of resorption lacunae,
neither in the absence or presence of nicotine. In PBMC cultures
maintained in M+R media, nicotine was able to promote an increase in
cell response (∼32% at day 21). Results are shown in Figure 4b.
3.3.5 | Scanning electron microscopy
Figure 4c shows representative SEM images of control unstimulated
and stimulated PBMC cultures and stimulated PBMC cultures exposed
to 32 ng/ml nicotine. Osteoclastic cells were randomly distributed on
the HA surface, in the three experimental conditions. Unstimulated
control cultures showed little evidence of resorption activity. By
contrast, osteoclastic cells associated with resorption lacunae were
well visible on control stimulated cultures. The presence of nicotine in
these cultures greatly increased the resorbing activity, evidenced by
the formation of resorption lacunae on the HA surface.
3.3.6 | Signaling pathways
PBMCcultures, exposed to 32 ng/ml nicotine, were assessed for TRAP
activity in the presence of several signaling pathway inhibitors
(Figure 5). In control PBMC cultures (unstimulated and stimulated),
TRAP activity was partially or totally inhibited in the presence of,
respectively, 1 and 10 μM U0126 (MEK inhibitor). PDTC (NFkB
inhibitor), at 10 and 100 μM, completely abolished TRAP synthesis.
Indomethacin (which blocks PGE2 synthesis) did not cause any
significant effect on the enzyme activity. In the cultures exposed to
nicotine, some TRAP activity was detected in the presence of 10 μM
U0126 and 10 μM PDTC, namely in stimulated cultures. In addition,
indomethacin elicited a significant decrease on TRAP activity, only in
cell cultures performed in the presence of M-CSF and RANKL.
3.3.7 | Contribution of RANKL signaling to the effect of
nicotine
PBMC cultures exposed to 32 ng/ml nicotine were treated with
antibodies anti-RANKL and were assessed for TRAP activity
(Figure 6a). Either in BM or M+R conditions, control PBMC cultures
revealed an almost total inhibition of TRAP activity (>95%).
Comparatively, in the presence of nicotine, the inhibition was about
79% (BM) or 47% (M+R).
3.3.8 | Levels of TNF-α and PGE2 released into the culture
medium
Culture medium from PBMC cultures was assessed for TNF-α and
PGE2 levels (Figure 6b). In BM, nicotine elicited an increase in the
production of TNF-α (51%) but did not affect PGE2 synthesis, while in
FIGURE 4 Quantification of (a) Ca2+ released to culture media, (b) total resorbed area and (c) SEM visualization of unstimulated (BM) and
stimulated (M+R) PBMC cultures exposed to nicotine and performed over HA disks. *Significantly different from the control
M+R, the production of either TNF-α or PGE2 was stimulated by
nicotine (about 86% and 169%, respectively).
4 | DISCUSSION
Although it is recognized that smoking can lead to skeletal
complications, affecting bone metabolism, and regeneration (Ahmed
&Mohammed, 2002; Baheiraei et al., 2005; Law & Hackshaw, 1997),
the effects of tobacco smoke components on bone cells and,
particularly, on osteoclastic cells, are far from being elucidated. Since
HA is widely used in bone regeneration therapies, due to its high
similarity to bone inorganic matrix (Dimitriou et al., 2011),
the present study examined the effect of nicotine on human
osteoclast precursor cells cultured over a HA surface, an issue that
was not previously addressed. Osteoclast precursors were cultured
in the absence or in the presence of the osteoclastogenic enhancers
M-CSF and RANKL, and were exposed to nicotine during 21 days.
The utilization of unstimulated osteoclast precursors allows to
investigate whether nicotine has the ability, by its own, to modulate
osteoclastogenesis, in the absence of M-CSF and RANKL. Since
osteoclast differentiation is a very complex process, potentially
involving multiple different cellular mechanisms, the possibility to
assess the influence of nicotine in the absence of the classic
osteoclastogenic modulators M-CSF and RANKL may reveal
important insights about the mechanism of action of nicotine in
the modulation of osteoclastogenesis.
First, dose-response curves (1.28 ng/ml to 500 μg/ml nicotine)
were established for PBMC cultured in standard cell culture plates,
covering the levels reported to be present in the plasma (4–75 ng/ml)
and saliva (96 ng/ml to 1.6 mg/ml) of smokers (Gritz, Baer-Weiss,
Benowitz, Van Vunakis, & Jarvik, 1981; Hoffmann & Adams, 1981;
James, Sayers, Drucker, & Hull, 1999; Russell, Feyerabend, & Cole,
1976; Russell, Jarvis, Iyer, & Feyerabend, 1980). Low concentrations of
nicotine, 32–160 ng/ml (unstimulated cultures) and 6.4–32 ng/ml
(stimulated cultures), did not affect total protein content neither
apoptosis but increased TRAP activity, reaching a maximum value at
32 ng/ml. At these levels, which are in the range of those reported to
be present in the plasma of smokers (Gritz et al., 1981; Russell et al.,
1976, 1980), the inductive effect was higher on unstimulated PBMC,
but nicotine was still able to further increase TRAP activity on the
cultures supplemented with M-CSF and RANKL. This observation
might suggest that nicotine may act by specific mechanisms on
osteoclast precursors, which can be partially overlapped by the
significant osteoclastogenic commitment elicited by the growth
factors. Higher concentrations (>160 ng/ml to 500 μg/ml), which are
representative of the nicotine salivary levels (Hoffmann & Adams,
1981; James et al., 1999), elicited a decrease on TRAP activity, and an
increase on apoptosis (for concentrations higher than 4 μg/ml).
Nicotine had a similar dose-dependent effect on TRAP activity by
PBMC cultured over HA surface. Low levels (32 ng/ml) increased
osteoclastogenic response, whereas levels ≥4 μg/ml elicited dose-
dependent deleterious effects in all analyzed parameters, including
total protein content, which suggests that nicotine at high levels may
FIGURE 5 Involvement of MEK, NFkB, and PGE2 production on unstimulated (BM) and stimulated (M+R) PBMC cultures exposed to
32 ng/ml nicotine. Cell cultures were performed in the presence of the corresponding signaling pathway inhibitors, and TRAP activity was
quantified. *Significantly different from cell cultures maintained in the absence of any inhibitor. Black arrows represent the main differences
observed in nicotine-treated cultures, compared to the corresponding negative controls (absence of nicotine)
become toxic to osteoclasts (and their precursors), promoting cell
death.
As referred above, cultures performed over HA and exposed to
32 ng/ml nicotine presented increased TRAP activity. In order to
understand this inductive effect, these cultures were characterized in
more detail for the osteoclastogenic response and the involved
mechanisms.
In unstimulated PBMC cultures, it was observed an inductive
effect on TRAP activity and gene expression. However, no effects
were observed in the expression of the important differentiation and
activation factors c-myc and c-src (Zhao et al., 2007), neither in the
functional CATK gene (Vaananen & Laitala-Leinonen, 2008). In line
with this, nicotine was unable to promote an increase in the resorbing
activity of these cells, as the levels of Ca2+ released into the culture
medium remained similar to those measured in control conditions.
Also, no resorption lacuna were observed in PBMC cultures
maintained in BM. Putting all together, the results suggest that in
the absence of M-CSF and RANKL, that means, in the absence of a
strong commitment of osteoclast precursors toward osteoclasto-
genesis, nicotine is able to promote some degree of osteoclastic
differentiation, but not the formation of fully mature bone-resorbing
osteoclasts.
PBMC cultures performed in the presence of M-CSF and RANKL
presented high TRAP activity, expression of osteoclastogenic genes
and resorbing activity, as expected due to the role of these molecules
on osteoclastic differentiation (Zhao et al., 2007). In these conditions,
that is, in osteoclast precursors on-going an active osteoclastogenic
differentiation, low concentrations of nicotine (32 ng/ml) caused an
increase on TRAP activity and gene expression, particularly in the case
of the activation factor c-src (Zhao et al., 2007) and in the gene
coding for the main osteoclastic protease CATK (Vaananen &
Laitala-Leinonen, 2008). The Ca2+ levels in the culture medium from
these cultures, as well as total resorbed area, were significantly higher
than those regarding control cultures, suggesting an important
increase in the resorbing activity of these cells. This observation is
in agreement with the SEM images of the cultures, showing evidence
of increased resorption in the cultures exposed to nicotine. Thus, in
opposition to what was observed in BM condition, in a context where
osteoclast precursors are actively engaged in their differentiation
process (M+R), nicotine appears to have the ability to potentiate
osteoclastogenesis, an effect particularly evident at the level of
osteoclast resorbing function.
In order to understand the mechanisms related to the pro-
osteoclastogenic effect elicited by low concentrations of nicotine, the
involvement of some intracellular pathways important for osteoclasto-
genesis was addressed. In control cultures, the NFkB pathway was
essential for osteoclast development, since the presence of a specific
inhibitor completely abolished TRAP synthesis. MEK pathway had also
FIGURE 6 Effects of nicotine in RANKL signaling (a) and TNF-α and PGE2 production in unstimulated (BM) and stimulated (M+R) PBMC
cultures performed over HA. (a) Cell cultures were treated with an isotype control antibody and with an anti-RANKL antibody and assessed
for TRAP activity. (b) TNF-α and PGE2 present in culture media were quantified in the absence and presence of nicotine. *Significantly
different from the control
a contribution, but PGE2 appeared not to be involved in the cell
response (TRAP activity was similar in the absence or the presence of
indomethacin). The most significant differences found in the cultures
exposed to nicotine were a slight downregulation of the NFkB
pathway (some TRAP activity in the presence of the lower
concentration of the inhibitor), and an important contribution of
PGE2, as the presence of indomethacin decreased significantly TRAP
activity.
In order to go one step further in the characterization of the
osteoclastogenic mechanisms modulated by nicotine, cell cultures
were treated with anti-RANKL antibody. In control cultures, this
caused a significant decrease in TRAP activity (>95%). However, in the
cultures exposed to nicotine, the decrease in TRAP activity was
significantly lower (∼50%). This suggests that RANKL signaling may
not be the sole activator of osteoclastogenesis in these experimental
conditions; this is in line with the small observed downregulation
elicited by nicotine in NFkB pathway (the main intracellular target of
RANKL [Blair & Zaidi, 2006; Zhao et al., 2007]). Regarding this, a
previous study suggested that the signaling mediated by acetylcholine
receptors activated with benzopyrene may cause a decrease in
RANKL-mediated osteoclastogenesis (Voronov, Heersche, Casper,
Tenenbaum, & Manolson, 2005; Voronov, Li, Tenenbaum, &
Manolson, 2008). Since nicotine binds to the same family of cellular
receptors, the present observed cellular response regarding RANKL
signaling may be related to a similar situation.
Nicotine is also known to affect inflammatory response, and there
are many inflammatory molecules that play an important stimulatory
role in osteoclastogenesis, such as TNF-α and PGE2 (Blair & Zaidi,
2006; Boyle et al., 2003; Zhao et al., 2007). The present study showed
that nicotine caused a significant increase in the production of TNF-α
(either in BMorM+R) and PGE2 (only inM+R), suggesting that nicotine
may also affect osteoclastogenesis by modulating the expression of
important pro-inflammatory molecules. Moreover, previous studies
also showed that nicotine increased the synthesis of PGE2 by platelets
and endothelial cells (Bull, Pittilo, Woolf, &Machin, 1988;Wennmalm,
1978), and by PBMC (Bernzweig, Payne, Reinhardt, Dyer, & Patil,
1998). Those results are in agreement and may also account for the
observed inhibitory effect on PBMC cultures, elicited by indometha-
cin, in the presence of nicotine.
At the present, only three papers were published regarding the
effects of nicotine on osteoclastic cells. Yuhara et al. (1999) showed
that nicotine (10–250 μg/ml) reduced the formation of TRAP-positive
multinucleated cells and the formation of resorption pits on slices of
dentine, on osteoclast-like cells formed on co-cultures of mouse bone
marrow cells and clonal stromal ST2 cells (Yuhara et al., 1999). In
another study, Henemyre et al. (2003), exposed porcine mature
osteoclasts to nicotine (0.03–1.50 μg/ml) and found that the number
of osteoclasts increased in a linear relationship with the increase on
nicotine concentration, although they did not find any correlation
between osteoclast number and the amount of resorption observed
(Henemyre et al., 2003). Recently, Tanaka et al. (2013) reported that
nicotine caused a negative effect in osteoclast resorbing ability in
RAW264.7 murine cell line treated with RANKL, for concentrations
≥16 μg/ml (Tanaka et al., 2013). Although with evident differences in
the experimental protocols, these studies suggest that nicotine, in the
microgram range, seems to cause negative effects on osteoclastic
behavior, as it was observed in the present work with human cells. The
variability in the reported cell response might also be related to the
different cell types used, that is, rat, porcine andmurine cells, stressing
the relevance of using human primary osteoclastic cells as a more
representative model to address this issue. Regarding the intracellular
mechanisms modulated by nicotine, no previously published works
addressed this issue.
In conclusion, this study demonstrate that, in PBMC cultures,
nicotine has the ability to act directly on human osteoclastic
precursors, inducing (low concentrations) or inhibiting (high concen-
trations) osteoclast differentiation. The inductive effect appears to be
dependent on the stage of osteoclastic differentiation (Figure 7). On
unstimulated precursors, nicotine increased TRAP activity and the
expression of several osteoclast-related genes, but did not signifi-
cantly affect the resorbing activity, which suggests that in this
condition nicotine only stimulates the first steps of osteoclastogenesis,
but it is not able to complete the process. By contrast, on osteoclastic
precursors engaged on a differentiation process, which ends up in
mature osteoclasts, nicotine greatly increased not only their differen-
tiation, but also their resorption activity. The modulation of RANKL
signaling and the expression of inflammatory molecules like TNFα and
PGE2 appeared to be involved in the inductive effect of nicotine.
Taken together, this is the first report with data on the effects of
nicotine on human osteoclast precursors cultured over HA. Results
showed that nicotine has dose-dependent effects on osteoclastic
behavior, with together with the reported effects over osteoblastic
cells, might contribute to disrupt the bone metabolic activities and,
consequently, normal bone remodeling at the bone/biomaterial
interface.
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